What is the next step for a 71-year-old male with increasing hypertension who is currently taking hydrochlorothiazide (HCTZ) 25 mg and losartan (angiotensin II receptor antagonist) 100 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a 71-year-old male with increasing blood pressure despite being on hydrochlorothiazide 25 mg and losartan 100 mg, the next step would be to add a calcium channel blocker such as amlodipine 5 mg daily. This approach is based on the principle that most patients with hypertension will require two or more medications to achieve goal blood pressure, as indicated in the NHLBI guidelines 1. The addition of amlodipine, which works by relaxing blood vessel walls, complements the existing medications that work through fluid reduction (hydrochlorothiazide) and angiotensin II receptor blockade (losartan).

Starting at 5 mg of amlodipine allows for potential dose escalation to 10 mg if needed after 2-4 weeks of monitoring. It is crucial to monitor blood pressure within 2-4 weeks of starting this additional medication, along with a basic metabolic panel to monitor electrolytes and kidney function. This strategy aligns with the recommendations for managing hypertension, especially in elderly patients, where gradual blood pressure lowering is advised to avoid complications 1.

Key considerations in this management plan include:

  • Monitoring for potential side effects of the added medication
  • Regular follow-up to assess the effectiveness of the treatment and to make adjustments as necessary
  • Emphasis on lifestyle modifications, such as diet and exercise, to support blood pressure control
  • Consideration for referral to a hypertension specialist if blood pressure remains uncontrolled after the addition of the calcium channel blocker. The American Heart Association and the American Diabetes Association also recommend that patients with diabetes and hypertension should be treated with a regimen that includes either an ACE inhibitor or an ARB, and other drug classes should be added as needed to achieve blood pressure targets 1.

From the FDA Drug Label

2.2 Hypertensive Patients with Left Ventricular Hypertrophy The usual starting dose is 50 mg of losartan once daily. Hydrochlorothiazide 12. 5 mg daily should be added and/or the dose of losartan should be increased to 100 mg once daily followed by an increase in hydrochlorothiazide to 25 mg once daily based on blood pressure response [see CLINICAL STUDIES (14.2)].

The patient is already taking losartan 100 mg and hydrochlorothiazide 25 mg. The next step to increase blood pressure is not directly stated in the label. No conclusion can be drawn. 2

From the Research

Increasing Blood Pressure in a 71-Year-Old Male

The patient is currently taking hydrochlorothiazide 25 mg and losartan 100 mg. To address the increasing blood pressure, consider the following:

  • The 2017 American College of Cardiology (ACC)/American Heart Association (AHA) hypertension guidelines recommend treatment of noninstitutionalized ambulatory community-dwelling adults aged 65 years and older with an average systolic blood pressure of 130 mm Hg or higher with lifestyle measures plus antihypertensive drug to lower the blood pressure to less than 130/80 mm Hg 3.
  • For elderly adults with hypertension and a high burden of comorbidities and limited life expectancy, clinical judgment, patient preference, and a team-based approach to assess risk/benefit is reasonable for decisions about the intensity of SBP lowering and the choice of antihypertensive drugs to use for treatment 3.
  • The combination therapy of losartan and hydrochlorothiazide has been shown to be effective in reducing blood pressure in hypertensive patients 4.
  • Losartan has also been found to have a renoprotective effect in patients with proteinuric chronic kidney disease and hypertension, independent of its antihypertensive action 5.
  • Consideration of the patient's overall health, comorbidities, and lifestyle should be taken into account when deciding on the next step in management, as outlined in the framework for improving blood pressure control in older adults 6.

Potential Next Steps

  • Continue to monitor the patient's blood pressure and adjust the treatment plan as needed.
  • Consider increasing the dose of losartan or adding another antihypertensive medication, such as a calcium channel blocker, to the treatment regimen.
  • Encourage lifestyle modifications, such as diet and exercise, to help lower blood pressure.
  • Assess the patient's kidney function and proteinuria, if applicable, to determine the best course of treatment.

Related Questions

What is the optimal management strategy for hypertension in geriatric patients?
What are the outpatient management options for a 76-year-old male with nocturnal hypertension (high blood pressure at night) and normal blood pressure during the morning and day, currently taking 100 mg losartan (angiotensin II receptor antagonist) daily?
What is the effect of taking losartan (Angiotensin II Receptor Antagonist) 50 milligrams orally (PO) daily and amlodipine (Calcium Channel Blocker) 5 milligrams orally (PO) daily?
What are the next steps for a 2-year-old female patient with stage 2 hypertension who remains hypertensive on Losartan (losartan) 25mg daily monotherapy?
What is the best option for adjusting the medication regimen for a patient with lower extremity (LE) edema and elevated blood pressure, currently taking Losartan (Angiotensin II receptor antagonist) 100 mg, Hydrochlorothiazide (HCTZ) (Thiazide diuretic) 25 mg, Spironolactone (Potassium-sparing diuretic) 50 mg, Amlodipine (Calcium channel blocker) 10 mg, and Benazepril (Angiotensin-converting enzyme inhibitor) 20 mg?
What is the significance of elevated White Blood Cell (WBC) count and neutrophils one month after a cortisone (corticosteroid) injection in the right shoulder?
What is the role of estrogen in treating vulvovaginal (atrophic vaginitis) atrophy?
What is the best investigation for umbilical (navel) discharge?
When is cancer debulking (cytoreductive surgery) contraindicated?
When is laryngeal cancer debulking (debulking of laryngeal tumor) contraindicated?
Does Sevelamer (Phosphate binder) alter the sense of taste?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.